Profund Advisors’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $183K | Sell |
19,853
-6,767
| -25% | -$62.4K | 0.01% | 923 |
|
|
2025
Q1 | $228K | Buy |
26,620
+11,240
| +73% | +$96.4K | 0.01% | 837 |
|
|
2024
Q4 | $165K | Sell |
15,380
-12,593
| -45% | -$135K | 0.01% | 1037 |
|
|
2024
Q3 | $159K | Sell |
27,973
-13,307
| -32% | -$75.6K | 0.01% | 1077 |
|
|
2024
Q2 | $174K | Sell |
41,280
-61,758
| -60% | -$261K | 0.01% | 1005 |
|
|
2024
Q1 | $524K | Buy |
103,038
+64,668
| +169% | +$329K | 0.02% | 561 |
|
|
2023
Q4 | $357K | Sell |
38,370
-7,595
| -17% | -$70.7K | 0.02% | 690 |
|
|
2023
Q3 | $301K | Sell |
45,965
-17,689
| -28% | -$116K | 0.02% | 663 |
|
|
2023
Q2 | $518K | Sell |
63,654
-22,258
| -26% | -$181K | 0.03% | 502 |
|
|
2023
Q1 | $736K | Buy |
+85,912
| New | +$736K | 0.05% | 386 |
|